Global reinsurers’ appetite for pension fund longevity risk is increasing rapidly leading to an increasing number of deals being done that transfer risk into this sector, according to Aon Hewitt, the adviser on the most recent transaction.
To continue reading, you need a subscription to Intelligent Insurer.
If you have already subscribed please login.
If you have any technical issues please contact support.
Reinsurers, longevity risk, Aon Hewitt, AstraZeneca
